Speech-Language Pathologists in Oberlin, OH Accepting Medicare

4 Speech-Language Pathologists found. Showing 1 - 4

Gina Olszowy Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 153 N Main St, Oberlin, OH 44074 Phone: 440-776-4655

Kidspeak, Llc Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: 23 Eric Nord Way Ste 1, Oberlin, OH 44074 Phone: 440-340-1233    Fax: 833-427-1421

Laura Elaine Slocum, M.A., CCC-SLP Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: 118 Woodhaven Pl, Oberlin, OH 44074 Phone: 614-668-7341

Holly Allsop, MA, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 10779 Vermilion Rd, Oberlin, OH 44074 Phone: 440-965-5381    Fax: 440-965-8849

News Archive

GPs must embrace digital technologies to make healthcare access easier for patients

Few now question that harnessing technology and digital innovation is critical to the future of the NHS. The model of booking a face-to-face appointment with your GP has barely changed since 1948 but the pressure on patients and doctors has changed beyond recognition.

Probiotics for kidney disorders to be showcased at ANNA 2019 in Dallas

Kibow Biotech, Inc., Pennsylvania, will feature its product for Kidney Illness, RENADYL™, at the 50th Anniversary Meeting of the American Nephrology Nurse Association (ANNA) in Dallas, Texas, USA.

Pacira provides updated timing for commercial launch of EXPAREL

Pacira Pharmaceuticals, Inc. today provided updated timing for its commercial launch of EXPAREL (bupivacaine liposome injectable suspension), a non-opioid analgesic that was approved by the U.S. Food and Drug Administration (FDA) for administration into the surgical site to produce postsurgical analgesia.

Weekly Digest releases report on investment opportunities in connection with the H1N1 outbreak

Weekly Digest (http://www.bullmarket.com/digest), a free investment research publication, announced the publication of a special report on investment opportunities in connection with the H1N1 "Swine Flu" Outbreak, including updated outlooks for GlaxoSmithKline, Sanofi-Aventis, Novartis, Baxter International, Roche Holding and several others.

Read more Medical News

› Verified 4 days ago